Cingulate Inc.
General ticker "CING" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $12.3M (TTM average)
Cingulate Inc. follows the US Stock Market performance with the rate: 24.3%.
Estimated limits based on current volatility of 5.4%: low 4.98$, high 5.55$
Factors to consider:
- Total employees count: 13 (-13.3%) as of 2023
- Top business risk factors: Insufficient funding, Economic downturns and volatility, Labor/talent shortage/retention, Regulatory and compliance, Cybersecurity threats
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.63$, 6.94$]
- 2026-12-31 to 2027-12-31 estimated range: [2.25$, 6.04$]
Short-term CING quotes
Long-term CING plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $19.94MM |
| Operating Income | $-19.94MM |
| Non-Operating Income | $-2.51MM |
| Interest Expense | $0.92MM |
| R&D Expense | $9.77MM |
| Income(Loss) | $-22.45MM |
| Profit(Loss)* | $-22.45MM |
| Stockholders Equity | $2.51MM |
| Assets | $15.07MM |
| Operating Cash Flow | $-17.25MM |
| Capital expenditure | $0.16MM |
| Investing Cash Flow | $-0.16MM |
| Financing Cash Flow | $16.15MM |
| Earnings Per Share** | $-4.13 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.